Prepare for Opill, the First OTC Oral Contraceptive

January 2024

Norgestrel 0.075 mg tablets (Opill) will be the first daily oral contraceptive to make the Rx-to-OTC switch.

Rx norgestrel (Ovrette) was discontinued in 2005 for business reasons, not safety or efficacy concerns. Now it’s back as OTC Opill.

The hope is to improve access to contraception. But it’s too soon to say if cost or coverage will be a barrier.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Contraceptives Prepare for Opill, the First OTC Oral Contraceptive
Obesity & Weight Loss Consider Pros and Cons of Zepbound or Wegovy for Obesity
Infectious Diseases Sort Through Antimicrobial Myths
Substance Use Disorder Manage Meds to Treat Alcohol Use Disorder
Insulin Be Ready to Help Patients Switch Insulin
Gastroenterology Don’t Jump to Voquezna for Erosive GERD
Antipsychotics Focus on Safety With Long-Acting Injectable Antipsychotics
NatMed Spotlight Give Guidance About Coenzyme Q10